Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

NCT00039325 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: dendritic cell-MART-1 peptide vaccine

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]